Molecular Quality Control Market Expected to Reach $240.87 Million Global Revenue by 2028 at a CAGR of 7.27%: Verified Market Research®

The main drivers of the global molecular quality control market are the increasing number of licensed medical laboratories, the expansion of third-party quality control and the growing propensity for assistance in external quality assessment.

JERSEY CITY, NJ, September 16, 2022 /PRNewswire/ — Verified Market Research recently published a report: “Molecular Quality Control MarketBy Product (Instrument Specific Controls, Independent Controls), By Analyte Type (Single Analyte Controls, Multi-Analyte Controls), By Application (Infectious Diseases, Genetic Testing), By End User (Clinical Laboratories, Hospitals), and By Geography.

According to the extensive research by Verified Market Research experts, the market has been rated $147.2 million in 2020 and is expected to be achieved $240.87 million to 2028 and growing at a CAGR of 7.27% from 2021 to 2028.

Download PDF brochure:

Browse the detailed table of contents on “Molecular Quality Control Market”

202 pages
37 – Numbers

Important Developments

  • in the June 2021, SeraCare collaborated with the International Quality Network for Pathology to develop, manufacture and deliver a series of highly characterized genomic cell line DNA and formalin-fixed, paraffin-embedded standards with proven low, intermediate and high mutational load within their exome regions.
  • in the May 2021, bio wheel has entered into a global partnership with Roche Diagnostics to offer its customers a full range of InteliQ products and Unity QC data management solutions, as well as customer training and device services.

Global Molecular Quality Control Market Overview

Molecular quality controls can be used to evaluate the effectiveness of in vitro nucleic acid testing procedures for viral load testing, universal health care diseases, and sexually transmitted disease infections. The main objective of these quality controls is to evaluate molecular diagnostic products for errors and to notify the administrative authorities. This determines the decision to reveal the product or not.

The increasing number of licensed clinical laboratories, increasing use of third-party quality controls, and a growing preference for outside help in quality assessment are the main factors driving the global molecular quality controls market. The number of laboratory tests performed has increased as the prevalence of various diseases has increased worldwide. Both the public and private sectors are increasing the number of laboratories to meet this requirement. Clinical laboratories in most countries are accredited by regulatory bodies such as the International Organization for Standardization and other similar standards to perform diagnostic tests. During the accreditation process, the competent authorities assess the competence and quality system of a laboratory based on specified standards. In addition, the development of molecular diagnostic tools for the detection of cancer and infectious diseases. The increase in the number of accredited clinical laboratories, the adoption of third-party quality control by end users, and the demand for outside assistance in quality assessment all contributed to the expansion of the market.

key figures

The main players in the market are Maine Molecular Quality Controls, Seracare Life Sciences, Inc., Roche Diagnostics, Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Theranostica, Bio-Rad Laboratories, Microbiologics, Inc., Qnostics, Grena Think Medical and Quidel.

Verified Market Research has segmented the global molecular quality control market based on product, analyte type, application, end-user and geography.

  • Molecular Quality Control Market by Product
    • Instrument specific controls
    • Independent controls
  • Molecular Quality Control Market by Analyte Type
    • single analyte controls
    • Multi-Analyte Controls
  • Molecular Quality Control Market by Application
    • infectious diseases
    • genetic test
    • oncology
    • Other Applications
  • Molecular Quality Control Market by End User
    • Academic and research institutes
    • Clinical Laboratories
    • IVD manufacturers and contract research institutes
    • hospitals
    • Miscellaneous
  • Molecular Quality Control Market by Geography
    • North America
    • Europe
      • Germany
      • France
      • United Kingdom
      • the rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • the rest of Asia Pacific
    • THE LINE
      • middle East & Africa
      • Latin America

Browse Related Reports:

Non-therapeutic biomolecules market by end-user (research, pharma and IVD), by IVD Moleculaire (oligonucleotides, plasmids and enzymes), by IVD IA (recombinant proteins, plasmids, enzymes), by Pharma ATM (recombinant proteins and plasmids), by Trad Pharma (enzymes, recombinant proteins), by Pharma CRO (enzymes, recombinant proteins), by Trad Pharma (enzymes, recombinant proteins, plasmids), by geography and prognosis

RSV Diagnostics Market by method (rapid antigen detection tests, molecular diagnostics), by product (kits and assays, instruments), by geography and forecast

Pharmacokinetics Services Market by Type (Small Molecule Services, Large Molecule Services), by Application (Small-Medium Enterprises, Large Enterprises), by Geographic Scope and Forecast, by Geography and Forecast

In Vitro Diagnostic Devices (IVD) Quality Control Products Market by Product (Quality Control Products, Quality Assurance Services), by Application (Clinical Chemistry, Immunochemistry, Hematology, Molecular Diagnostics, Others), by Geography, and Forecast

The 10 leading point-of-care molecular diagnostics companies offering enhanced testing methods

Visualize the Molecular Quality Control Market with Verified Market Intelligence – :

Verified Market Intelligence is ours BI-enabled platform for narrative storytelling in this market. VMI provides detailed forecast trends and in-depth insights into over 20,000 emerging and niche markets, helping you make critical revenue decisions for a bright future.

VMI provides a holistic view and global competitive landscape in terms of region, country, segment and major players of your market. Present your market report and findings with an integrated presentation feature that saves over 70% of your time and resources for investor, sales and marketing, R&D, and product development meetings. VMI enables data delivery in Excel and interactive PDF formats with 15+ key market indicators for your market.

about us

Verified Market Research is a leading global research and advisory firm serving more than 5000 clients. Verified Market Research offers advanced analytical research solutions while providing information-enriched research studies. We provide insights into strategy and growth analytics, data needed to achieve business goals and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance, using industry techniques to collect and analyze data on more than 15,000 major and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, domain knowledge and years of collective experience to produce informative and accurate research results.

We examine more than 14 categories covering Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communications Technology, Software & Services, Information Security, Mining, Minerals & Metals as well as Building & Construction, Agribusiness and Medical Devices from over 100 countries.

Contact us

Mister. Edwyne Fernandes
Verified Market Research®
United States: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
United States toll-free: +1 (800)-782-1768
Follow us: LinkedIn | Twitter


SOURCE Verified Market Research

Leave a Comment